Sep 20, 2024
Product Launch
Introducing the Next Generation PCR Testing Platform
CO-DX unveils revolutionary portable PCR system designed for point-of-care testing in various healthcare settings with enhanced speed and accuracy.
Read the article →
Learn more about our enhanced in vitro diagnostic (IVD) testing capabilities
Choose from a range of CoMira's Logix Smart® products that include RNaseP Internal Positive Control (IPC) and are compatible with most qPCR equipment.
Multiplex assay for simultaneous detection of multiple respiratory pathogens
FDA Emergency Use Authorization for SARS-CoV-2 detection
Mycobacterium tuberculosis detection for clinical diagnosis
Dual-target detection for enhanced specificity
Droplet sequencing technology for variant detection
Zika, Dengue, and Chikungunya virus multiplex detection
Zika virus detection for clinical and travel diagnostics
Get the peace of mind that only comes from the gold standard of infectious disease testing
Get accurate test results with our proprietary Co-Primers™ technology. Compatible with most qPCR equipment. Includes RNaseP Internal Positive Control (IPC).
Cut costs related to single-use PCR tests with multiplexing capabilities
All CoMira Diagnostic solutions have passed extensive quality control to ensure they meet our goal of producing high-quality diagnostics that exceed customer expectations.
Solutions are offered as in vitro diagnostics (IVDs) only where they are in compliance with the registration and regulatory requirements of importing countries, including approvals by the appropriate regulatory bodies as necessary.
Contact us for a full demo of our IVD solutions
Sep 20, 2024
Product Launch
CO-DX unveils revolutionary portable PCR system designed for point-of-care testing in various healthcare settings with enhanced speed and accuracy.
Read the article →Oct 5, 2024
Partnership
CO-DX partners with international health organizations to deploy PCR testing in emerging markets, bringing advanced diagnostics to underserved communities worldwide.
Read the article →Oct 12, 2024
Company News
CO-DX announces FDA EUA approval for its rapid PCR COVID-19 test kit, enabling faster diagnostic testing nationwide and expanding access to reliable molecular diagnostics.
Read the article →